• About
    • Research and Development
    • Board of Directors
    • Management Team
    • LipimetiX
    • Careers
    • Safe Harbor Statement
  • Contact Us
  • Investors
    • Filings
    • Annual Report
    • Corporate Governance
    • Events and Presentations
    • Analyst Coverage
Capstone Therapeutics

Contact Us

Corporate Headquarters:  Capstone Therapeutics Corp.
1275 West Washington Street
Suite 104
Tempe, AZ 85281
Map and Directions
Phone:  800.937.5520 (Toll Free)
602.286.5520 (Local)
Feedback:  Contact Capstone Therapeutics Corp.
Human Resources:  jobs@capstonethx.com
Investor Relations:  investorinquiries@capstonethx.com
Audit Committee:  auditcommittee@capstonethx.com
Compliance Hot Line:  602.286.5479

Connect With Us

  • @CapstoneTHX
  • Facebook
  • Google+
  • LinkedIn
  • The Chairman’s Blog
  • LipimetiX

Site Info

  • Legal Disclaimer
  • Outlook Web Access
  • Investors

Stock Ticker

  • Loading stock data...

Press Releases

Press Release June 21, 2022
\nCAPSTONE HOLDING CORP. ANNOUNCES EXERCISE OF SECURED DEBT AND INTEREST CONVERSION OPTION BY MAJORITY SHAREHOL...
Press Release December 2, 2021
\nCAPSTONE THERAPEUTICS CORP. ANNOUNCES RESULTS OF ANNUAL MEETING\n...
Press release November 12, 2021
\nThe Annual Meeting of Stockholders of Capstone Therapeutics Corp. will be held on Thursday, December 1, 2021\n...
Press Release April 6, 2021
\nCAPSTONE THERAPEUTICS CORP. ANNOUNCES TRANSACTION WITH DIAMOND PRODUCTS HOLDINGS, LLC\n...
Press Release March 31, 2020
\nCAPSTONE THERAPEUTICS ANNOUNCES OPERATING RESULTS FOR FISCAL 2020 – INCLUDING A CHANGE IN ITS DEFERRED TAX ...
Press Release February 18, 2021
\nCAPSTONE THERAPEUTICS ANNOUNCES RESULTS OF SPECIAL SHAREHOLDER MEETING, AND A LICENSE TRANSFER/ROYALTY AGREEM...
Press Release December 28, 2020
\nCapstone Therapeutics Announces Exercise of Secured Debt and Interest Conversion Option by BP Peptides, LLC a...
Press Release March 27th, 2020
\nCapstone Therapeutics Annouces Transaction With TotalStone LLC\n...
Press Release May 7, 2018 - 09:00 ET
LipimetiX Development Announces Sub-License of APO E Mimetic Peptide Platform to Anji Pharma, China...
Press Release July 17, 2017 - 09:00 ET
CAPSTONE THERAPEUTICS ANNOUNCES TRANSACTION FOR SALE OF SHARES OF ITS COMMON STOCK and SECURED LOAN...
Copyright ©2022 Capstone Therapeutics. All rights reserved.
Top